Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 274-286.e10
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

A growth-differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons
William B. Smith, D. Le Nguyen, Timothy M. Clough, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 3
Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy
Marlena S. Fejzo, Nuno Rocha, I Cimino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Metabolic Syndrome and Pharmacological Interventions in Clinical Development
Eugen Javor, David Šarčević, Arnes Rešić
Diabetology (2024) Vol. 5, Iss. 3, pp. 300-320
Open Access | Times Cited: 2
Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
Julie Jacobsen, Natalia Petersen, Lola Torz, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114501-114501
Open Access | Times Cited: 2
Central mechanisms of emesis: A role for GDF15
Tito Borner, Allison M. Pataro, Bart C. De Jonghe
Neurogastroenterology & Motility (2024)
Open Access | Times Cited: 2
GDF15 is still a mystery hormone
Casper M. Sigvardsen, Michael M. Richter, Sarah Engelbeen, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
GDF15 Promotes the Osteogenic Cell Fate of Periodontal Ligament Fibroblasts, thus Affecting Their Mechanobiological Response
Lukas Lösch, Albert Stemmler, Adrian Fischer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10011-10011
Open Access | Times Cited: 6
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 6
A long‐acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model
Songmao Zheng, David Polidori, Yuanping Wang, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 8, pp. 1431-1444
Open Access | Times Cited: 5
Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus
Carlijn A. Hoekx, Maaike E. Straat, Maurice B. Bizino, et al.
Experimental Physiology (2024) Vol. 109, Iss. 8, pp. 1292-1304
Open Access | Times Cited: 1
Bitter-tasting drugs tune GDF15 and GLP-1 expression via bitter taste or motilin receptors in the intestine of patients with obesity
Qian Wang, Mona Farhadipour, Theo Thijs, et al.
Molecular Metabolism (2024) Vol. 88, pp. 102002-102002
Open Access | Times Cited: 1
Design of novel therapeutics targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) to aid weight loss
Iona Davies, Tricia Tan
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 6, pp. 659-669
Open Access | Times Cited: 3
Cancer cachexia as a blueprint for treating obesity
Nikolai Jaschke, Tilman D. Rachner
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 7, pp. 395-403
Open Access | Times Cited: 3
Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors
Mohamed A. Gouda, Mimi I. Hu, Maria E. Cabanillas, et al.
Annals of Oncology (2023) Vol. 34, Iss. 10, pp. 946-948
Open Access | Times Cited: 3
Identification of GDF15 peptide fragments inhibiting GFRAL receptor signaling
Flora Alexopoulou, Nina Buch‐Månson, Søren L. Pedersen, et al.
Peptides (2023) Vol. 168, pp. 171063-171063
Open Access | Times Cited: 2
Identification and characterization of human GDF15 knockouts
Allan Gurtan, Shareef Khalid, Christopher Koch, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Decoding green food safety information dependency in the digital era: An intelligent validation using SEM-ANN framework
Tong Zhao, Qiumei Shi, X.S. Zhang, et al.
Journal of Retailing and Consumer Services (2024) Vol. 79, pp. 103886-103886
Closed Access
Cold exposure increases circulating fibroblast growth factor 21 in the evening in males and females
Carlijn A. Hoekx, Borja Martínez‐Téllez, Maaike E. Straat, et al.
Endocrine Connections (2024) Vol. 13, Iss. 7
Open Access
Skeletal Muscle Specific PolG Dysfunction Activates the Integrated Stress Response and Promotes a Cachexia like Phenotype
Simon T. Bond, E. King, Shannen Walker, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature
Carla Igual-Gil, Christopher A. Bishop, Markus Jähnert, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosis
Germana Cocozza, Ludovica Maria Busdraghi, Giuseppina Chece, et al.
Brain Behavior and Immunity (2024) Vol. 124, pp. 280-293
Open Access
Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges
Jincheng Zhang, Jingquan Sun, Jielang Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 24
Open Access
Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling
Claire H. Feetham, Valeria Collabolletta, Amy A. Worth, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Targeting GDF15 as a potential therapy for low back pain originating from endplate
Xiaoqun Li, Jinhui Wu, Qing‐Jie Kong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Plasma GDF15 levels are not modified in response to weight loss induced by liraglutide in patients with type 2 diabetes mellitus
Maaike Straat, Maurice B. Bizino, Huub J. van Eyk, et al.
Research Square (Research Square) (2023)
Open Access

Scroll to top